The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma

被引:0
|
作者
Pilotti S. [1 ]
Della Torre G. [2 ]
Mezzelani A. [1 ]
Tamborini E. [1 ]
Azzarelli A. [3 ]
Sozzi G. [2 ]
Pierotti M.A. [2 ]
机构
[1] Dept. of Pathology and Cytopathology, Ist. Naz. per lo Studio e la Cura, 1-20133 Milano, Via G. Venezian
[2] Department of Experimental Oncology, Ist. Naz. per lo Studio e la Cura, 1-20133 Milano, Via G. Venezian
[3] Dept. of Surg. of Soft Tissue Tumors, Ist. Naz. per lo Studio e la Cura, 1-20133 Milano, Via G. Venezian
关键词
CDK4; Differential diagnosis; Lipoma; Liposarcoma lipoma-like; MDM2;
D O I
10.1054/bjoc.1999.1090
中图分类号
学科分类号
摘要
Ordinary lipomas are cytogenetically characterized by a variety of balanced rearrangements involving chromosome segment 12q13-15, whereas well differentiated liposarcomas (WDL) show supernumerary ring and giant marker chromosomes, known to contain amplified 12q sequences. The tight correlation between the presence of ring chromosomes and both amplification and overexpression of MDM2 and CDK4 genes suggests the exploration of the possibility that immunocytochemistry (ICC) might assist in the differential diagnosis of lipoma-like well differentiated liposarcomas (LL-WDL) and large deep-seated lipomas (LDSL). For this purpose, 21 cases of the former and 19 cases of the latter tumours were analysed by ICC and, according to the availability of material, by molecular and cytogenetic approaches. All lipomas displayed a null MDM2/CDK4 phenotype, whereas all LL-WDL showed MDM2/CDK4 or CDK4 phenotypes. Southern blot analysis performed on 16 suitable cases, complemented by fluorescence in situ hybridization and classical cytogenetic analysis in 11 cases, was consistent with, and further supported the immunophenotyping data. In conclusion, MDM2/CDK4 product-based immunophenotyping appears to represent a valuable method for the categorization of arguable LDSL. (C) 2000 Cancer Research Campaign.
引用
下载
收藏
页码:1271 / 1275
页数:4
相关论文
共 50 条
  • [41] MDM2 and CDK4 expression in carcinosarcoma of the esophagus: Comparison with squamous cell carcinoma and review of the literature
    Nikitakis, NG
    Drachenberg, CB
    Papadimitriou, JC
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2002, 73 (03) : 198 - 208
  • [42] Gnathic giant-cell-rich conventional osteosarcoma with MDM2 and CDK4 gene amplification
    Hirose, Katsutoshi
    Okura, Masaya
    Sato, Sunao
    Murakami, Shumei
    Ikeda, Jyun-Ichiro
    Noda, Yuri
    Fukuda, Yasuo
    Morii, Eiichi
    Toyosawa, Satoru
    HISTOPATHOLOGY, 2017, 70 (07) : 1171 - 1173
  • [43] Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of Concept, Phase Ib Study
    Razak, Albiruni R. Abdul
    Bauer, Sebastian
    Suarez, Cristina
    Lin, Chia-Chi
    Quek, Richard
    Huetter-Kroenke, Marie Luise
    Cubedo, Ricardo
    Ferretti, Stephane
    Guerreiro, Nelson
    Jullion, Astrid
    Orlando, Elena J.
    Clementi, Giorgia
    Dejmek, Janna Sand
    Halilovic, Ensar
    Fabre, Claire
    Blay, Jean-Yves
    Italiano, Antoine
    CLINICAL CANCER RESEARCH, 2022, 28 (06) : 1087 - 1097
  • [44] Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma
    Weaver, Joshua
    Goldblum, John R.
    Turner, Sondra
    Tubbs, Raymond R.
    Wang, Wei-Lein
    Lazar, Alexander J. F.
    Rubin, Brian P.
    MODERN PATHOLOGY, 2009, 22 (01) : 66 - 70
  • [45] Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers
    Cassinelli, Giuliana
    Pasquali, Sandro
    Lanzi, Cinzia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Dedifferentiated Liposarcoma With Meningothelial-like Whorls, Metaplastic Bone Formation, and CDK4, MDM2, and p16 Expression: A Morphologic and Immunohistochemical Study
    Thway, Khin
    Robertson, David
    Thway, Yi
    Fisher, Cyril
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (03) : 356 - 363
  • [47] Co-amplification of CDK4 and MDM2 plus HMGA2 fusion in a patient with myogenic differentiation dedifferentiated liposarcoma.
    Huang, Gang
    Li, Xianan
    Wang, Chunyang
    He, Qifan
    Wang, Xiaojuan
    CANCER RESEARCH, 2021, 81 (13)
  • [48] Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours
    Tos, APD
    Doglioni, C
    Piccinin, S
    Sciot, R
    Furlanetto, A
    Boiocchi, M
    Dal Cin, P
    Maestro, R
    Fletcher, CDM
    Tallini, G
    JOURNAL OF PATHOLOGY, 2000, 190 (05): : 531 - 536
  • [49] The value of MDM2 and CDK4 amplification levels using real-time PCR and fish for the differential diagnosis of liposarcomas and their histologic mimickers
    Hirose, Takanori
    Shimada, Shio
    Ishizawa, Keisuke
    Harada, Hiroshi
    Matsumura, Tadaki
    Hasegawa, Tadashi
    MODERN PATHOLOGY, 2006, 19 : 181 - 181
  • [50] MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition
    Kovatcheva, Marta
    Liu, David D.
    Dickson, Mark A.
    Klein, Mary E.
    O'Connor, Rachael
    Wilder, Fatima O.
    Socci, Nicholas D.
    Tap, William D.
    Schwartz, Gary K.
    Singer, Samuel
    Crago, Aimee M.
    Koff, Andrew
    ONCOTARGET, 2015, 6 (10) : 8226 - 8243